13 insiders have filed at SUPN since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Khattar Jack A. | President, CEO | 3.16M | 5.477% | 22 sells $29.4M | |
| Newhall Charles W III | Director | 124.1k | 0.215% | 7 sells $2.0M | |
| Siebert John M | Director | 87.9k | 0.153% | ||
| Martin Tami Tillotson | SR. V.P., Regulatory Affairs | 86.9k | 0.151% | 3 sells $645k | |
| Hudson Frederick M. | Director | 60.4k | 0.105% | 5 sells $1.2M | |
| Gemayel Georges | Director | 27.3k | 0.047% | 6 sells $2.3M | |
| Barlow Carrolee | Director | 27.0k | 0.047% | ||
| Mottola Frank | SVP, Chief Tech. Ops. Officer | 18.4k | 0.032% | 7 sells $2.5M | |
| Bhatt Padmanabh P. | SR. VP Of Ip, Cso | 17.0k | 0.03% | 19 sells $10.1M | |
| Rubin Jonathan | SVP, Chief Medical Officer | 13.3k | 0.023% | 1 sells $36k | |
| Dec Timothy C | Senior Vice-President & CFO | 8.2k | 0.014% | 1 sells $524k | |
| Horich William Todd | SVP, Commercial Operations | 4.8k | <0.01% | 2 sells $484k | |
| Sensenig Bethany | Director | 3 sells $455k |
Full register at boothcheck.com/insiders/SUPN. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.